John Roderick

520 total citations
14 papers, 301 citations indexed

About

John Roderick is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, John Roderick has authored 14 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in John Roderick's work include Cell Adhesion Molecules Research (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Protease and Inhibitor Mechanisms (3 papers). John Roderick is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Protease and Inhibitor Mechanisms (3 papers). John Roderick collaborates with scholars based in United States and Germany. John Roderick's co-authors include Chu‐Biao Xue, Carl P. Decicco, William F. DeGrado, Rui‐Qin Liu, Maryanne Covington, James M. Trzăskos, James J.‐W. Duan, Richard E. Olson, Robert Newton and Shaker A. Mousa and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

John Roderick

13 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Roderick United States 12 138 128 95 57 48 14 301
Zhonghui Lu United States 9 169 1.2× 186 1.5× 101 1.1× 58 1.0× 40 0.8× 12 370
Aaron Maurais United States 7 204 1.5× 80 0.6× 71 0.7× 56 1.0× 50 1.0× 8 364
Stephen C. Yabut United States 10 210 1.5× 205 1.6× 37 0.4× 25 0.4× 27 0.6× 14 417
Attilla Ting United Kingdom 13 267 1.9× 100 0.8× 164 1.7× 92 1.6× 24 0.5× 17 467
Sarah A. Dorwin United States 8 148 1.1× 46 0.4× 51 0.5× 68 1.2× 18 0.4× 9 294
Grace E. Munie United States 14 212 1.5× 95 0.7× 204 2.1× 222 3.9× 34 0.7× 17 478
Geoff Mellor United Kingdom 5 176 1.3× 67 0.5× 89 0.9× 105 1.8× 9 0.2× 5 357
David J. Calderwood United States 9 180 1.3× 133 1.0× 116 1.2× 15 0.3× 12 0.3× 12 381
Sai Kumar Chakka South Africa 12 139 1.0× 164 1.3× 28 0.3× 46 0.8× 20 0.4× 17 314
Leonard C. Weir United States 7 232 1.7× 149 1.2× 122 1.3× 31 0.5× 12 0.3× 8 418

Countries citing papers authored by John Roderick

Since Specialization
Citations

This map shows the geographic impact of John Roderick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Roderick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Roderick more than expected).

Fields of papers citing papers by John Roderick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Roderick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Roderick. The network helps show where John Roderick may publish in the future.

Co-authorship network of co-authors of John Roderick

This figure shows the co-authorship network connecting the top 25 collaborators of John Roderick. A scholar is included among the top collaborators of John Roderick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Roderick. John Roderick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sheppeck, James E., John L. Gilmore, Xiaotao Chen, et al.. (2006). Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE). Bioorganic & Medicinal Chemistry Letters. 17(5). 1413–1417. 23 indexed citations
2.
Xue, Chu‐Biao, Xiaotao Chen, John Roderick, et al.. (2004). Synthesis and structure–activity relationship of a novel sulfone series of TNF-α converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(17). 4453–4459. 27 indexed citations
3.
Batt, Douglas G., John Roderick, Joseph B. Santella, et al.. (2004). N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 787–791. 12 indexed citations
4.
Xue, Chu‐Biao, John Roderick, James J.‐W. Duan, et al.. (2003). Rational design, synthesis and structure–Activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 1: lead identification. Bioorganic & Medicinal Chemistry Letters. 13(24). 4293–4297. 21 indexed citations
5.
Xue, Chu‐Biao, John Roderick, James J.‐W. Duan, et al.. (2003). Rational design, synthesis and structure–activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 2: lead optimization. Bioorganic & Medicinal Chemistry Letters. 13(24). 4299–4304. 26 indexed citations
6.
Duan, James J.‐W., Zhonghui Lu, Chu‐Biao Xue, et al.. (2003). Discovery of N-Hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-α converting enzyme (TACE). Bioorganic & Medicinal Chemistry Letters. 13(12). 2035–2040. 29 indexed citations
7.
Xue, Chu‐Biao, et al.. (2002). Asymmetric Synthesis of trans-2,3-Piperidinedicarboxylic Acid and trans-3,4-Piperidinedicarboxylic Acid Derivatives. The Journal of Organic Chemistry. 67(3). 865–870. 17 indexed citations
8.
Xue, Chu‐Biao, John Roderick, Zelda R. Wasserman, et al.. (2001). Discovery of Macrocyclic Hydroxamic Acids Containing Biphenylmethyl Derivatives at P1‘, a Series of Selective TNF-α Converting Enzyme Inhibitors with Potent Cellular Activity in the Inhibition of TNF-α Release. Journal of Medicinal Chemistry. 44(21). 3351–3354. 35 indexed citations
9.
Xue, Chu‐Biao, John Roderick, Shaker A. Mousa, Richard E. Olson, & William F. DeGrado. (1998). Synthesis and antiplatelet effects of an isoxazole series of glycoprotein IIb/IIIa antagonists. Bioorganic & Medicinal Chemistry Letters. 8(24). 3499–3504. 28 indexed citations
10.
Xue, Chu‐Biao, John Roderick, William F. DeGrado, et al.. (1998). Design and Synthesis of Cyclic Inhibitors of Matrix Metalloproteinases and TNF-α Production. Journal of Medicinal Chemistry. 41(11). 1745–1748. 39 indexed citations
11.
Xue, Chu‐Biao, John Roderick, Sharon M. Jackson, et al.. (1997). Design, synthesis, and in vitro activities of benzamide-core glycoprotein IIb/IIIa antagonists: 2,3-Diaminopropionic acid derivatives as surrogates of aspartic acid. Bioorganic & Medicinal Chemistry. 5(4). 693–705. 13 indexed citations
12.
Xue, Chu‐Biao, Maria Rafalski, John Roderick, et al.. (1996). Design, synthesis and in vitro activities of a series of benzimidazole/benzoxazole glycoprotein IIb/IIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(3). 339–344. 22 indexed citations
13.
Xue, Chu‐Biao, et al.. (1996). Potent matrix metalloproteinase inhibitors: Amino-carboxylate compounds containing modifications of the P1 residue. Bioorganic & Medicinal Chemistry Letters. 6(4). 379–384. 8 indexed citations
14.
Roderick, John. (1993). Covering China: The Story of an American Reporter from Revolutionary Days to the Deng Era. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026